Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant
2011
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
2015 StandoutNobel
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
2022 StandoutNobel
Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor
2010
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation
2013
Interleukin-7 Mediates Selective Expansion of Tumor-redirected Cytotoxic T Lymphocytes (CTLs) without Enhancement of Regulatory T-cell Inhibition
2013
Regulatory T cells in autoimmune kidney diseases and transplantation
2023 StandoutNobel
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Hydrophobic mismatch drives self-organization of designer proteins into synthetic membranes
2024 StandoutNobel
WNT Signaling in Cancer Immunosurveillance
2018
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
2020
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Genetic engineering of T cells for immunotherapy
2021
Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
2018 StandoutNobel
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
2016 StandoutNobel
Improving the safety of T-Cell therapies using an inducible caspase-9 gene
2016
Delivery technologies for cancer immunotherapy
2019 Standout
Recent updates on CAR T clinical trials for multiple myeloma
2019
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Inflammatory Effects of High and Moderate Intensity Exercise—A Systematic Review
2020 Standout
Chimeric antigen receptors: driving immunology towards synthetic biology
2016
Family and Academic Stress and Their Impact on Students' Depression Level and Academic Performance
2022 Standout
CARs on Track in the Clinic
2011
Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
2013
Systematic review and meta-analysis of depression, anxiety, and suicidal ideation among Ph.D. students
2021
Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial
2015
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
mRNA transcript therapy
2014 StandoutNobel
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
CAR-T cell therapy: current limitations and potential strategies
2021 Standout
Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients
2017
Respiratory Virus Infections in Hematopoietic Cell Transplant Recipients
2019
Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy
2011
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes
2016 StandoutNobel
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
2017 Standout
Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response
2018 StandoutNobel
Adoptive Immunotherapy for Cancer or Viruses
2014
Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene
2014
Design and development of therapies using chimeric antigen receptor‐expressing T cells
2013
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
2011 Standout
Acute Myeloid Leukemia
2015 Standout
Recovery of the immune system after exercise
2016
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity
2017
Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation
2013
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
CRISPR therapeutic tools for complex genetic disorders and cancer (Review)
2018
Generation of allo-antigen-specific induced Treg stabilized by vitamin C treatment and its application for prevention of acute graft versus host disease model
2017
Loss of TET proteins in regulatory T cells promotes abnormal proliferation, Foxp3 destabilization and IL-17 expression
2019 StandoutNobel
A Conservative Staggered-Grid Chebyshev Multidomain Method for Compressible Flows
1996
High‐order CFD methods: current status and perspective
2013 Standout
Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation
2015
Antibody-modified T cells: CARs take the front seat for hematologic malignancies
2014
Chimeric Antigen Receptor Therapy
2018 Standout
Going viral: chimeric antigen receptor T‐cell therapy for hematological malignancies
2014
Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation
2020 StandoutNobel
Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant
2013
Strategies for Combining Immunotherapy with Radiation for Anticancer Therapy
2015 StandoutNobel
Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT
2014
Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art
2016
Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells
2011
Works of Patrick J. Hanley being referenced
Graft Versus Leukemia Response Without Graft-versus-host Disease Elicited By Adoptively Transferred Multivirus-specific T-cells
2014
Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization
2019
A single exercise bout enhances the manufacture of viral-specific T-cells from healthy donors: implications for allogeneic adoptive transfer immunotherapy
2016
Generation of Polyclonal CMV-specific T Cells for the Adoptive Immunotherapy of Glioblastoma
2012
Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein–Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation
2011
The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care
2014
The effects of age and latent cytomegalovirus infection on the redeployment of CD8+ T cell subsets in response to acute exercise in humans
2013
Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes
2016
Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against Cancer
2019
Adoptive immunotherapy with the use of regulatory T cells and virus-specific T cells derived from cord blood
2015
CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo
2015
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation
2009
A Strategy for the Efficient Simulation of Viscous Compressible Flows Using a Multi-domain Pseudospectral Method
1993
Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy
2013
Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation
2010
Activation of Wnt Signaling Arrests Effector Differentiation in Human Peripheral and Cord Blood-Derived T Lymphocytes
2011
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes
2009
Controlling Cytomegalovirus: Helping the Immune System Take the Lead
2014